Cargando…
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
High-density lipoproteins (HDLs) are unique in that they play an important role in the reverse cholesterol transport process. However, reconstituted HDL (rHDL) infusions have demonstrated limited beneficial effect in clinical practice. This is perhaps a consequence of the limited cholesterol efflux...
Autores principales: | Morin, Emily E., Guo, Yanhong, He, Hongliang, Yuan, Wenmin, Souery, Whitney N., Fawaz, Maria V., Chen, Yuqing Eugene, Schwendeman, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772318/ https://www.ncbi.nlm.nih.gov/pubmed/33390931 http://dx.doi.org/10.3389/fphar.2020.513031 |
Ejemplares similares
-
rHDL modeling and the anchoring mechanism of LCAT activation
por: Laurenzi, Tommaso, et al.
Publicado: (2020) -
HDL in sepsis – risk factor and therapeutic approach
por: Morin, Emily E., et al.
Publicado: (2015) -
Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma
por: Sabnis, Nirupama, et al.
Publicado: (2013) -
Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications
por: Aranda-Lara, Liliana, et al.
Publicado: (2022) -
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
por: Guo, Yanhong, et al.
Publicado: (2017)